Trial Search Results

Evaluation of Preexisting Immunity Markers in Human Tumor Tissue Sample

The purpose of this study is to evaluate markers of immune response in human tumor samples.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Stanford University

Stanford Investigator(s):

Eligibility


Inclusion Criteria:Any adult patient with a tumor who is scheduled to undergo surgery to
either remove or biopsy the tumor.

Exclusion Criteria:Patients without tumor and pediatric patients (children) will be
excluded.

Ages Eligible for Study

18 Years - N/A

Genders Eligible for Study

All

Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Robin Malone Cisco
6507245570
Not Recruiting